Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
41 - 50 out of 94Page size: 10
Sort by: 1st author
  1. Published

    Response to Aviv et al

    Helleberg, M., Niemann, Carsten, Moestrup, K. S., Kirk, Ole, Lebech, Anne-Mette & Lundgren, Jens, 2 Aug 2021, In: The Journal of Infectious Diseases. 224, 3, p. 559-561 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  2. Published

    Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy

    Helleberg, M., Niemann, Carsten, Moestrup, K. S., Kirk, Ole, Lebech, Anne-Mette, Lane, C. & Lundgren, Jens, 2020, In: Journal of Infectious Diseases. 222, 7, p. 1103-1107 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)

    Hengeveld, P. J., Ertem, Y. E., Dubois, J. M. N., Mellink, C. H. M., van der Kevie-kersemaekers, A., Evers, L. M., Heezen, K., Kolijn, P. M., Mook, O. R. F., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P. E., Niemann, Carsten, Kater, A. P., Langerak, A. W. & Levin, M., 2022, In: Leukemia. 36, 7, p. 1935-1938 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  4. Published

    Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: Protocol for a retrospective population-based cohort study

    Hleuhel, M. H., Ben-Dali, Y., Da Cunha-Bang, C., Brieghel, C., Clasen-Linde, E., Niemann, Carsten & Andersen, M. A., 2019, In: BMJ Open. 9, 3, 5 p., e023566.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut

    Huber, H., Tausch, E., Schneider, C., Edenhofer, S., von Tresckow, J., Robrecht, S., Giza, A., Zhang, C., Fürstenau, M., Dreger, P., Ritgen, M., Illmer, T., Illert, A. L., Dürig, J., Böttcher, S., Niemann, C. U., Kneba, M., Al-Sawaf, O., Kreuzer, K. A., Fink, A. M. & 5 others, Fischer, K., Döhner, H., Hallek, M., Eichhorst, B. & Stilgenbauer, S., 2023, In: Blood. 142, 11, p. 961-972 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia

    Huber, H., Edenhofer, S., von Tresckow, J., Robrecht, S., Zhang, C., Tausch, E., Schneider, C., Bloehdorn, J., Fürstenau, M., Dreger, P., Ritgen, M., Illmer, T., Illert, A. L., Dürig, J., Böttcher, S., Niemann, C. U., Kneba, M., Fink, A-M., Fischer, K., Döhner, H. & 3 others, Hallek, M., Eichhorst, B. & Stilgenbauer, S., 2022, In: Blood. 139, 9, p. 1318-1329 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

    Husby, Simon, Bæch-Laursen, C., Eskelund, C. W., Favero, Francesco, Jespersen, Jakob Schmidt, Hutchings, M., Pedersen, L. B., Niemann, Carsten, Weischenfeldt, Joachim Lütken, Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M. & Grønbæk, Kirsten, 2022, In: Leukemia. 36, p. 2912-2916

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score

    Jensen, C. M., Costa, J. C., Nørgaard, J. C., Zucco, Adrian G., Neesgaard, B., Niemann, Carsten, Ostrowski, Sisse Rye, Reekie, J., Holten, B., Kalhauge, A., Matthay, M. A., Lundgren, Jens, Helleberg, Marie & Moestrup, K. S., 2022, In: Scientific Reports. 12, 21019.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

    Jerkeman, M., Eskelund, C. W., Hutchings, M., Räty, R., Wader, K. F., Laurell, A., Toldbod, H., Pedersen, L. B., Niemann, Carsten, Dahl, C., Kuitunen, H., Geisler, C. H., Grønbæk, Kirsten & Kolstad, A., 2018, In: The Lancet Haematology. 5, 3, p. e109-e116 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

    Kater, A. P., Levin, M. D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., van der Kevie-Kersemaekers, A. M. F., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Brieghel, C., Mattsson, M., Bellido, M., Tran, H. T. T. & 2 others, Nasserinejad, K. & Niemann, Carsten, 2022, In: The Lancet Oncology. 23, 6, p. 818-828 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next

ID: 185059285